title: Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
authors.forename: Lynn E
authors.initials: LE
authors.lastname: Taylor
authors.forename: Josiah D
authors.initials: JD
authors.lastname: Rich
authors.forename: Karen T
authors.initials: KT
authors.lastname: Tashima
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology; D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications* / Q000276:immunology; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a